Current portfolio
Hutchmed
Among the first global-focused novel drug discovery companies in China
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
![](https://cdn.sanity.io/images/30p7so6x/eqt-web-prod/361d515fd468a979f8467a75e4c6909155f01279-1018x626.png?rect=50,0,919,626&w=705&h=480&fit=crop&auto=format)
- SectorHealthcare
- CountryGreater China
- FundBPEA Private Equity Fund VII
- Entry2021
- Web
![Hutchmed](https://cdn.sanity.io/images/30p7so6x/eqt-web-prod/209ffc35deef06529bf8b5f4192fb117bb01a4c2-576x163.png?h=50&fit=scale)